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Summary
In many meta-analysis cases the estimator of the overall eect in independent
trials or experiments leads to unjustied signicant results. This paper con-
siders trials with two arms where the summary statistic of interest is either
the mean dierence or the risk dierence. By using convexity principles of the
relevant composed functions and the moments of the chi-square distribution,
corrections are made on the estimated standard deviation of the estimator of
the overall treatment dierence. It is shown, analytically and by simulations,
that by making such corrections on the estimated standard deviation, signi-
cance levels are attained which are relatively closer to the nominal level.
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1. Introduction and Notations
There are many areas (e.g. medicine, epidemiology and education) where
the combination of results from dierent trials (studies or experiments) has
become common. For example, a situation may arise where one has to assess
the overall treatment dierence when samples from the dierent trials are
either homoscedastic or heteroscedastic. Recent studies by Li et al. (1994)
and Boeckenho/Hartung (1998) attest to the fact that there is a systematic
overestimate in the signicance levels when combining studies in xed eects
models which may be due to the underestimate of the variance of the estimator
of the overall treatment mean. If one considers trials which are comparative in
nature, then measures of the common treatment dierence may take dierent
forms, for instance, mean dierences or eect sizes for quantitative data, and
risk dierences, (logarithm) relative risks, or (logarithm) odds ratios for binary
data. By considering the mean dierence and the risk dierence we show both
analytically and by simulations that by making corrections on the estimated
standard deviation of the overall mean dierence (or overall risk dierence)
signicance levels can be obtained which are relatively closer to the nominal
level.
Suppose there are K "two-armed" (multicenter) trials in a meta-analysis.Let
x
jil
be the lth observation in arm j of trial i; i = 1 ; : : : ; K; j= 1 ;2; l =
1; : : : ; n
ji
where n
ji
is the total number of observations in arm j of trial i:
Then the mean of the jth arm of study i is x
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=
P
n
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l=1
x
jil
=n
ji
 (
ji
; 
2

ji
=n
ji
);
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2
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= 
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
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=n
ji
: Dene y
i
= x
1i
  x
2i
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1i
  y
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
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); i = 1 ; : : : ; K; j= 1 ;2; is one of the summary statistics available
from arm j of study i for a meta-analysis.
Further, dene
y
i
= + e
i
; i = 1 ; : : : ; K; (1)
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where e
i
 (0; 
2
i
); and it is assumed that  = 
1i
  
2i
is common in all the
studies. In this formulation, y
i
could be the mean dierence for quantitative
data or the risk dierence for binary data.
2. Estimation
Normal Data
Let y
ji
 N (
ji
; 
2
ji
); i = 1 ; : : : ; K; j= 1 ;2 ( 
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= 
j
independent of trial
number i); so that y
i
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i
); with 
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= 
2
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+ 
2
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i
 N (0; 
2
i
); for
i = 1 ; : : : ; K:
The best estimator of  in each trial is the individual sample treatment dier-
ence
^
i
= ^
1i
  ^
2i
= y
1i
  y
2i
;
Due to variation in sample sizes and precision of the trials, and absence of
treatment-by-centre interaction, the best estimator of the underlying treatment
dierence (that is common to all trials) is a weighted estimate, namely
^ =
1
P
K
i=1
1=
2
i
K
X
i=1
1

2
i
 y
i
; (2)
with the associated variance ( cf: Whitehead/Whitehead, 1991)

2
^
=
1
P
K
i=1
1=
2
i
(3)
Let s
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; for i = 1 ; : : : ; K; j= 1 ;2: Then the estimate of 
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Therefore, the estimate of  is given by
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Further, we have that
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Binomial Data
For binary data, let y
ji
be binomially distributed with parameters n
ji
and p
ji
;
i = 1 ; : : : ; K;j=1,2. Therefore, y
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  ^
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1i
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2i
approx
 N (; 
2
i
);
with  = p
1i
  p
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1
  p
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; assumed identical in all the trials, i=1,. . . ,K and
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It is sucient in our case to approximate V ar(^
2
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) by the delta-method, thus
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which is estimated by replacing p
ji
with p^
ji
:
In both the normal and binomial populations, to set condence intervals and
testing hypotheses, we use the corresponding statistic
T =
^

^
^
approx
 N (; 1): (11)
The estimator ^
^
is biased and underestimates 
^
: This can easily be shown
by using the concavity of ^
2
^
in ^
2
i
and Jensen's inequality (cf: Hartung, 1977
and Li, et al.,1994). That is,
E(^
^
)  
^
:
4
Trials where the estimator ^
^
, which underestimates 
^
, is used in obtaining
T are often bound to be unjustiably signicant. Tables 1 and 2 below give
some actual simulated signicance levels for testing the hypothesis H
0
:  = 0
against a two sided alternative H
1
:  6= 0 at  = 0 :05 for dierent con-
stellations of (n
1i
; n
2i
) and ( 
2

1i
; 
2

2i
); i = 1 ; : : : ; K, for K=3 for normal and
binomial data.
Table 1: Actual simulated signicance levels for K=3 (Normal data).
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
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
12
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
22
) ( 
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
13
; 
2

23
) ^%
(5,6) (6,7) (7,5) (1,4) (3,4) (5,4) 10.3
(1,5) (3,3) (5,1) 10.5
(1,10) (3,30) (5,50) 13.1
(10,10) (10,10) (10,10) (1,4) (3,4) (5,4) 8.3
(1,5) (3,3) (5,1) 8.1
(1,10) (3,30) (5,50) 9.2
Table 2: Actual simulated signicance levels for K=3 (Binomial data).
(n
11
; n
21
) ( n
12
; n
22
) ( n
13
; n
23
) ( p
1
;
2
) ^%
(7,13) (10,7) (15,10) (0.3,0.3) 6.0
(0.4,0.4) 6.8
(0.5,0.5) 7.1
(0.6,0.6) 6.6
(0.7,0.7) 6.2
All of the attained signicance levels given in Tables 1 and 2 are larger than
the expected nominal level of 5%. Our concern is in the methods which will
make the attained signicance levels closer to the nominal level.
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3. Some Theoretical Results
Dene on IR
K
+
the function f(x) =
P
K
i=1
1=x
i
; then f is convex, and h(x) =
1=f(x) is quasi-concave. Next, dene h(0) = 0; then h(x) =   h(x);   0;
x > 0; implies that h is positively homogeneous; so together with the quasi-
concavity it follows that h is concave (cf: Hartung, 1976, section1).
By Jensen's inequality, if f is convex, then Ef(x)  f(Ex) and the reverse is
true if f is concave.
Now, consider ^
2
i
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;
for i = 1 ; : : : ; K:
This facilitates the denition of the following approximate moments and in-
verse moments of the chi-square distribution(cf: Patel et al., 1976 ):
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This can be proved as follows:
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by using the convexity of
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by the concavity of
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; which is seen to be similar to h(x) above.
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with
^
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ned in (17) and the control parameter 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4. Simulation Results
To demonstrate how the proposed methods perform, a simulation study is car-
ried out with the number of trials, K=3, 6 and 9 for both the normal and
binomial cases. Dierent constellations of unbalanced heteroscedastic samples
are considered as shown in Tables 3.a., 3.b., 3.c. for the normal case and Ta-
bles 4.a., 4.b., 4.c. for the binomial case.
To get an impression of how these procedures perform for relatively large trials,
we started with K=3 and made independent replications to give K=6, denoted
by 2!; and K=9, denoted by 3!; see the Tables below. Further, for K=6,
for example, replication was done such that n
11
= n
14
; n
21
= n
24
; n
12
= n
15
;
n
22
= n
25
; n
13
= n
16
; n
23
= n
26
and similarly for variances in the normal case.
For K=9, n
11
= n
14
= n
17
; n
21
= n
24
= n
27
; n
12
= n
15
= n
18
; n
22
= n
25
= n
28
;
n
13
= n
16
= n
19
; n
23
= n
26
= n
29
:
Used also in the Tables are the following representations:
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and ^
^
(
^
; ) as in (18).
Table 3.a.: Simulated actual signicance levels (10 000 runs) at nominal level
 = 5% for K=3 and H
0
:  = 0 vs H
1
:  6= 0 with test statistic as in (11)
and dierent estimators for the standard deviation with a
1
= ( n
11
; n
21
); a
2
=
(n
12
; n
22
); a
3
= ( n
13
; n
23
) and b
1
= ( 
2

11
; 
2

21
); b
2
= ( 
2

12
; 
2

22
); b
3
= ( 
2

13
; 
2

23
):
Test statistic, T = ^

=
Sample Sizes Variances ^%

a
1
a
2
a
3
b
1
b
2
b
3

^
^
^
^
^
(c) ^
^
(
^
; 0:5) ^
^
(c
3
)
(6,13) (10,6) (15,10) (1,4) (3,6) (5,3) 6.0 7.9 6.0 4.6 5.4
(10,40) (30,60) (50,30) 6.0 8.0 6.0 4.7 5.4
(20,80) (60,120) (100,60) 6.1 8.3 6.6 5.0 5.8
(12,26) (20,12) (30,20) (1,4) (3,6) (5,3) 5.7 6.6 5.7 4.4 5.4
(10,40) (30,60) (50,30) 5.3 6.3 5.3 3.8 4.9
(20,80) (60,120) (100,60) 5.8 6.6 5.8 4.4 5.5
From Tables 3.a c and 4.a c; we see that results with ^
^
always overestimate
the nominal signicance level. This overestimate is relatively more pronounced
for the normal case (Tables 3.a  c).
Using ^
^
(c) results in signicance levels which are in the same order of magni-
tude with the levels of 
^
; notice the large number of levels which are actually
equal for the normal case, Tables 3.a  c: The results of ^
^
(c) in the binomial
case are in the same order of magnitude with those of ^
^
; Tables 4.a  c:
By using ^
^
(
^
; 0:5) and ^
^
(c
3
) we obtain further improvements of signicance
levels. The advantage with ^
^
(
^
; 0:5) is that we can obtain more improvements
by varying the control parameter, :
There does not seem to be any sensitivity of the test statistics to changes in
the number of trials and the error variances.
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Table 3.b.: Simulated actual signicance levels (10 000 runs) at nominal level
 = 5% for K=6 and H
0
:  = 0 vs H
1
:  6= 0 with test statistic as in (11)
and dierent estimators for the standard deviation.
Test statistic, T = ^

=
Sample Sizes Variances ^%

2 a
1
2 a
2
2 a
3
2 b
1
2 b
2
2 b
3

^
^
^
^
^
(c) ^
^
(
^
; 0:5) ^
^
(c
3
)
(6,13) (10,6) (15,10) (1,4) (3,6) (5,3) 6.8 9.0 6.8 5.3 6.3
(10,40) (30,60) (50,30) 6.7 8.8 6.6 5.1 6.0
(20,80) (60,120) (100,60) 6.2 8.0 6.1 4.8 5.5
(12,26) (20,12) (30,20) (1,4) (3,6) (5,3) 5.8 6.7 5.8 4.4 5.5
(10,40) (30,60) (50,30) 5.7 7.1 5.8 4.4 5.5
(20,80) (60,120) (100,60) 5.4 6.5 5.5 4.0 5.2
Table 3.c.: Simulated actual signicance levels (10 000 runs) at nominal level
 = 5% for K=9 and H
0
:  = 0 vs H
1
:  6= 0 with test statistic as in (11)
and dierent estimators for the standard deviation.
Test statistic, T = ^

=
Sample Sizes Variances ^%

3 a
1
3 a
2
3 a
3
3 b
1
3 b
2
3 b
3

^
^
^
^
^
(c) ^
^
(
^
; 0:5) ^
^
(c
3
)
(6,13) (10,6) (15,10) (1,4) (3,6) (5,3) 6.7 8.7 6.7 5.1 6.0
(10,40) (30,60) (50,30) 6.7 9.1 6.8 5.2 6.1
(20,80) (60,120) (100,60) 6.6 8.6 6.5 5.1 6.0
(12,26) (20,12) (30,20) (1,4) (3,6) (5,3) 5.8 6.7 5.7 4.3 5.4
(10,40) (30,60) (50,30) 5.8 6.7 5.7 4.3 5.4
(20,80) (60,120) (100,60) 5.9 6.9 5.9 4.5 5.6
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Table 4.a.: Simulated actual signicance levels (10 000 runs) at nominal level
 = 5% for K=3 and H
0
:  = 0 vs H
1
:  6= 0 with test statistic like
(11) and dierent estimators for the standard deviation with a
1
= ( n
11
; n
21
);
a
2
= ( n
12
; n
22
); a
3
= ( n
13
; n
23
):
Test statistic, T = ^

=
Sample Sizes ^%

a
1
a
2
a
3
(p
1
; p
2
) 
^
^
^
^
^
(c) ^
^
(
^
; 0:5) ^
^
(c
3
)
(7,13) (10,7) (15,10) (0.3,0.3) 5.1 6.0 5.8 5.0 4.7
(0.4,0.4) 5.9 6.8 6.6 6.0 5.7
(0.5,0.5) 6.2 7.1 7.0 6.5 6.4
(0.6,0.6) 5.7 6.7 6.5 5.9 5.8
(0.7,0.7) 5.2 6.2 6.0 5.1 4.7
(15,25) (20,15) (30,20) (0.3,0.3) 4.9 5.4 5.3 4.9 4.8
(0.4,0.4) 5.2 5.6 5.6 5.5 5.5
(0.5,0.5) 5.7 6.0 6.0 5.9 5.9
(0.6,0.6) 5.2 5.6 5.6 5.5 5.5
(0.7,0.7) 5.2 5.6 5.5 5.2 5.1
Table 4.b.: Simulated actual signicance levels (10 000 runs) at nominal level
 = 5% for K=6 and H
0
:  = 0 vs H
1
:  6= 0 :with test statistic like (11) and
dierent estimators for the standard deviation.
Test statistic, T = ^

=
Sample Sizes ^%

2 a
1
2 a
2
2 a
3
(p
1
; p
2
) 
^
^
^
^
^
(c) ^
^
(
^
; 0:5) ^
^
(c
3
)
(7,13) (10,7) (15,10) (0.3,0.3) 6.1 6.6 6.5 5.5 5.2
(0.4,0.4) 6.3 6.9 6.8 6.3 6.2
(0.5,0.5) 6.7 7.2 7.2 6.8 6.7
(0.6,0.6) 6.5 7.0 6.9 6.4 6.3
(0.7,0.7) 5.7 6.3 6.1 5.1 4.9
(15,25) (20,15) (30,20) (0.3,0.3) 5.2 5.6 5.6 5.2 5.2
(0.4,0.4) 5.4 5.6 5.6 5.4 5.4
(0.5,0.5) 5.5 5.8 5.8 5.7 5.7
(0.6,0.6) 5.8 6.1 6.1 5.9 5.9
(0.7,0.7) 5.2 5.7 5.6 5.2 5.1
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Table 4.c.: Simulated actual signicance levels (10 000 runs) at nominal
level  = 5% for K=9 and H
0
:  = 0 vs H
1
:  6= 0 with test statistic like
(11) and dierent estimators for the standard deviation.
Test statistic, T = ^

=
Sample Sizes ^%

3 a
1
3 a
2
3 a
3
(p
1
; p
2
) 
^
^
^
^
^
(c) ^
^
(
^
; 0:5) ^
^
(c
3
)
(7,13) (10,7) (15,10) (0.3,0.3) 6.0 6.6 6.4 5.2 5.0
(0.4,0.4) 6.9 7.6 7.6 6.8 6.8
(0.5,0.5) 6.8 7.3 7.3 6.8 6.7
(0.6,0.6) 6.6 7.1 7.1 6.5 6.4
(0.7,0.7) 5.7 6.2 5.9 5.1 4.9
(15,25) (20,15) (30,20) (0.3,0.3) 5.5 5.7 5.7 5.4 5.4
(0.4,0.4) 6.0 6.3 6.3 6.0 6.0
(0.5,0.5) 6.3 6.5 6.5 6.4 6.4
(0.6,0.6) 5.4 5.6 5.6 5.4 5.4
(0.7,0.7) 5.4 5.8 5.7 5.4 5.3
5. Conclusion
In this article we have illustrated analytically and by simulations that attained
signicance levels could be improved by using suitable weights for the estimated
standard deviation of the estimator of the overall treatment dierence. The
use of the methods developed is recommended especially when the number of
trials is small.
A further investigation in this direction is to nd out which methods are suit-
able when the measure of treatment eect is, for example, the eect sizes.
The extension of these procedures to cases when there is treatment-by-center-
interaction is also possible.
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